紫杉醇脂质体联合草酸铂及希罗达治疗晚期胃癌的初步报告(2)
 |
| 第1页 |
参见附件。
参考文献
[1]普绍平，杨懿昆，高文桂，等。草酸铂的合成及其结构表征[J]。贵金属，2002，21(1)：26。
[2]ARMANDJP， 孙燕，管忠震。草酸铂(奥沙利铂)治疗大肠癌的研究进展[J]。癌症，1999，18(6)：624-630
[3]Schuller J， Cassidy J， Dumont E， et al. Preferential activation of capecitabine in tumor following oral administration in colorectal cancer patients [J]. Cancer Chemoher Pharmacol， 2000，45(4)：291-297.
[4]Kang Y， Kang W， Shin B， et al.Capecitabine / cisplatin (XP) vs.continuous infusion of 5-FU / cisplatin(FP) as first line therapy in patients with advanced gastric cancer (AGC)：
efficacy and safety results [C]. ProcASCO-06 [Abst 4018].
[5]K0bayashi M。Oba K，Sakamoto J，et a1.Pharmaeokinetic study 0fweekly administration dose at"paclitaxel in patients with advanced or recurrent gastric cancer in Japan.Gastric Cancer，2007。10：52-57.
[6]Grem几，Nguyen D，Monahan BP，et a1.Sequence·dependent antagonism between tluorouracil and paclitaxel in human breast cancer cells.Biochem Pharmacol。1999。58：477486.
[7]Yeh KH，Lu YS，Hsu CH，et a1.Phrase II study of weekly paclitaxel and 24..hour infusion of hish..dose 5-fluomuracil and leucovorin in the treatment ofphraseⅡem or metastatic gastric cancer.Ontology.2005.69：88-95.
[8]Matsubara J，Shimada Y，Takashirna A，et a1.A phase I study of bolus 5.fluorouracil and leueovorin combined with weekly paclitaxel(FLTAX) first·line therapy for advanced gastric cancer.Jpn J Clin Oncol，2008。38：540-546.
[9]滕小玉，管忠震，姚志文，等.晚期实体癌患者对不含聚氧乙烯蓖麻油注射用紫杉醇白蛋白纳米粒悬浮液的临床耐受性研究.癌症，2004，23(1l Suppl)：1431-1436.
您现在查看是摘要介绍页，详见PDF附件。